Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
ECL Chemiluminescent Substrate Detection Kit
2026-09-23
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) supports horseradish peroxidase (HRP) chemiluminescence for immunoblotting on nitrocellulose and PVDF membranes. Product information reports low-picogram protein sensitivity, an optimized 6–8-hour signal duration, and a working-reagent stability period of 24 hours.
-
2-Thio-dCTP: An Assay-Design Framework
2026-09-22
2-Thio-dCTP is more than a modified DNA building block: it is a controlled way to interrogate polymerase selectivity, DNA recognition, and assay specificity. This guide connects nucleotide chemistry with the SCP4–H3T3 chromosome-stability study while clearly separating established evidence from exploratory applications.
-
Medroxyprogesterone Acetate: Mechanism and Workflows
2026-09-22
Medroxyprogesterone acetate (MPA) is a synthetic progestin that supports research on progesterone signaling, renal epithelial regulation, neurobiology, and hormone-related disease models. Its documented activity includes progesterone receptor binding, progesterone receptor-independent regulation of α-ENaC through glucocorticoid receptor activity, and concentration-dependent effects in M-1 renal collecting duct cells.
-
MLKL Polymerization Links Lysosomal Damage to Necroptosis
2026-09-21
The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a critical execution step in necroptosis. By combining live-cell imaging with cathepsin B inhibition, knockdown, and MLKL-domain perturbation, it connects lysosomal rupture to protease-dependent cell death and provides a framework for testing this pathway in disease-relevant models.
-
KR-12 Antimicrobial Peptides: Design and Applications
2026-09-21
The 2024 review maps how KR-12, a compact fragment of human cathelicidin LL-37, can be redesigned through sequence modification, conjugation, stapling, cyclization, nanoformulation, and biomaterial immobilization. Its practical significance lies in combining antimicrobial, antibiofilm, endotoxin-neutralizing, and immune-regulatory functions while identifying the safety, delivery, and translation issues that remain unresolved.
-
ISRIB (trans-isomer) Workflows for ER Stress
2026-09-20
Use ISRIB (trans-isomer) to connect PERK–eIF2α–ATF4 biology with practical ER stress, apoptosis, and memory experiments. This workflow emphasizes timing, orthogonal readouts, formulation control, and the inflammation-associated forgetting model reported in mice.
-
PDK4-IN-1 hydrochloride Research Workflows
2026-09-19
PDK4-IN-1 hydrochloride enables selective PDH activation for cell-based metabolism assays and translational studies of metabolic, cardiac, and tumor biology. This guide connects pathway principles with practical dosing, flux readouts, controls, and troubleshooting strategies.
-
From CD38 CAR Design to Precise Apoptosis Readouts
2026-09-18
Structural studies of CD38 CAR binders show why affinity, epitope engagement, and fratricide must be optimized together. This thought-leadership article explains how Annexin V-PE Reagent can translate those design questions into sensitive, mechanistically informed apoptosis and cell-death measurements.
-
Mubritinib (TAK 165): Redox-Aware Assay Design
2026-09-18
Mubritinib (TAK 165) is best understood through the metabolic context of complex I inhibition, NAD+/NADH balance, and oxygen availability. This guide translates redox biology into practical assay decisions for AML, PEL, and HER2-related cancer biology research.
-
CFDA-SE in CD38 Surface Biology Studies
2026-09-17
CFDA-SE converts cell division into a quantitative fluorescence history for immune, stromal, and bacterial models. This article explains how to pair proliferation tracking with CD38 surface-proximity biology without confusing changes in cell number with changes in adhesion, migration, or membrane organization.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-17
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations, providing a more physiologically relevant model of tumor heterogeneity and drug response. The study shows that stromal composition alters gene expression and treatment sensitivity, supporting assembloids as a platform for investigating resistance mechanisms and personalized therapy.
-
Toremifene vs Tamoxifen in Advanced Breast Cancer
2026-09-16
This Cochrane review directly compared toremifene and tamoxifen for advanced breast cancer across tumor response, disease control, survival, and adverse events. Its main contribution was a structured synthesis of head-to-head evidence, which found no persuasive efficacy advantage for either drug and supports individualized treatment selection rather than routine substitution.
-
Sodium chloride B7288: Buffer and QC Guide
2026-09-16
Sodium chloride B7288 is an inorganic salt used to set ionic strength and support osmotic balance in aqueous buffers, biochemical assays, and cell culture media. Use it as a water-soluble NaCl laboratory reagent, not as a DMSO or ethanol stock, a pH buffer, or a substitute for sterility-qualified material.
-
Lyophilized mRNA-LNPs for Stable mAb Expression
2026-09-15
Wang et al. evaluated lyophilization as a strategy for reducing the cold-chain burden of monoclonal antibody-encoding mRNA lipid nanoparticles. A formulation containing 5 mM Tris at pH 8 with 10% sucrose preserved particle properties, mRNA encapsulation, and in vivo antibody expression after one month at room temperature, supporting further development of dry mRNA-LNP dosage forms.
-
Cistanche Nanovesicles Protect Sertoli Cells
2026-09-15
This reference study identifies Cistanche deserticola exosome-like nanovesicles as a potential intervention for cyclophosphamide-induced testicular injury. Its central mechanistic finding is that vesicle-delivered miR159b-3p is taken up by Sertoli cells through heparan sulfate proteoglycan-dependent processes and relieves P21-associated cell cycle arrest through CDK1 activation.